BSE Fundamental Analysis - Balance Sheet & Share Holding Pattern

PARNAXLAB01 Jan 1900

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in

PARNAXLAB01 Jan 1900

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
31-Mar-2024	BC	Pursuant to Regulation 30 read with Schedule III of Security and Exchange Board of India (LODR) Regulation, 2015, we wish to inform you that Mr. Vinayak Desai (DIN: 03185850), has completed his secon	31-Mar-2024
03-Feb-2024	BC	PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve Standalone and Consolidated Un-audited IND- AS	13-Feb-2024
02-Nov-2023	BC	PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve Standalone and Consolidated Un-audited IND- A	09-Nov-2023
11-Aug-2023	BC	Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) 2015, we wish to inform you that the Board of Directors of the Company at it	29-Sep-2023
06-Sep-2023	BC	We wish to inform you that the 41st Annual General Meeting of the Members of the Company will be held on Friday, 29th September, 2023 at 12:30 P.M. (IST) through Video Conferencing ('VC') / Other aud	23-Sep-2023

No Rights has been declared by PARNAXLAB

Book Closure

Record Date	Split Date	Purpose
31-Mar-2024	-	Pursuant to Regulation 30 read with Schedule III of Security and Exchange Board of India (LODR) Regulation, 2015, we wish to inform you that Mr. Vinayak Desai (DIN: 03185850), has completed his secon
13-Feb-2024	-	PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve Standalone and Consolidated Un-audited IND- AS
09-Nov-2023	-	PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve Standalone and Consolidated Un-audited IND- A
29-Sep-2023	-	Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) 2015, we wish to inform you that the Board of Directors of the Company at it
23-Sep-2023	01 Jan'1900	We wish to inform you that the 41st Annual General Meeting of the Members of the Company will be held on Friday, 29th September, 2023 at 12:30 P.M. (IST) through Video Conferencing ('VC') / Other aud

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Lupin Ltd ₹1,616.15(+5.55/0.34%)	1,616.15	+5.55	73,656.05	120.62	31.66	3.57
Ipca Laboratories Ltd ₹1,316.45(+23.15/1.79%)	1,316.45	+23.15	33,398.89	87.17	60.72	5.39
J B Chemicals & Pharmaceuticals Ltd ₹1,798.50(-4.10/-0.23%)	1,798.50	-4.10	27,911.78	72.51	54.99	10.37
Sanofi India Ltd ₹8,246.25(-127.20/-1.52%)	8,246.25	-127.20	18,991.11	48.07	32.16	18.70
IOL Chemicals & Pharmaceuticals Ltd ₹380.50(-3.05/-0.80%)	380.50	-3.05	2,233.74	-3.65	12.98	1.41

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	2.77	1.83	1.13	2.44	1.16	0.76
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	2.77	1.83	1.13	2.44	1.16	0.76
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.12	0.18	0.11	0.14	0.13	0.03
Total Income	2.89	2.01	1.25	2.58	1.29	0.78
Total Expenditure	1.54	1.13	1.11	1.52	1.04	0.82
PBIDT	1.36	0.88	0.14	1.06	0.25	-0.03
Interest	0.01	0.07	0.04	0.03	0.06	0.05
PBDT	1.34	0.81	0.10	1.03	0.19	-0.08
Depreciation	0.01	0.02	0.01	0.03	0.01	0.01
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.34	0.19	0.02	0.27	0.07	-0.05
Reported Profit After Tax	0.99	0.60	0.07	0.73	0.11	-0.04
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	0.99	0.60	0.07	0.73	0.11	-0.04

EPS (Unit Curr.)	0.86	0.52	0.06	0.66	0.10	-0.04
EPS (Adj) (Unit Curr.)	0.86	0.52	0.06	0.66	0.10	-0.04
Calculated EPS (Unit Curr.)	0.86	0.52	0.06	0.63	0.10	-0.04
Calculated EPS (Adj) (Unit Curr.)	0.86	0.52	0.06	0.63	0.10	-0.04
Calculated EPS (Ann.) (Unit Curr.)	3.44	2.08	0.23	2.53	0.38	-0.15
Calculated EPS (Adj) (Ann.) (Unit Curr.)	3.44	2.08	0.23	2.53	0.38	-0.15
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	11.49	11.49	11.49	11.49	11.49	11.49
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	49.10	48.09	12.39	43.44	21.55	-3.95
PBDTM(%)	48.38	44.26	8.85	42.21	16.38	-10.53
PATM(%)	35.74	32.79	6.19	29.92	9.48	-5.26

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	50.99	42.61	48.74	40.91	46.82	43.14
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	50.99	42.61	48.74	40.91	46.82	43.14
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.10	0.22	0.24	0.27	0.08	0.30
Total Income	51.09	42.83	48.99	41.18	46.91	43.43
Total Expenditure	45.02	37.33	42.25	36.17	39.45	37.57
PBIDT	6.07	5.51	6.74	5.01	7.46	5.86
Interest	1.35	1.43	1.16	1.18	1.30	1.20
PBDT	4.72	4.08	5.58	3.82	6.16	4.66
Depreciation	1.78	1.74	1.60	1.59	1.74	1.55
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.27	0.17	0.88	0.79	1.04	0.71
Deferred Tax	0.49	0.30	-0.23	0.00	0.22	0.30
Reported Profit After Tax	2.18	1.87	3.33	1.44	3.16	2.10
Minority Interest After NP	0.00	0.00	0.01	0.00	0.01	0.00
Net Profit after Minority Interest	2.18	1.87	3.32	1.44	3.15	2.10

Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	2.18	1.87	3.32	1.44	3.15	2.10

EPS (Unit Curr.)	1.90	1.63	2.90	1.30	2.96	1.83
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	11.49	11.49	11.49	11.49	11.49	11.49

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	11.90	12.93	13.83	12.25	15.93	13.58
PBDTM(%)	9.26	9.58	11.45	9.34	13.16	10.80
PATM(%)	4.28	4.39	6.83	3.52	6.75	4.87

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	11.49	9.81	8.50	8.50	8.50	8.50
Reserves Total	7.87	1.12	-3.79	-2.68	-0.68	0.15
Equity Share Warrants	0.00	1.82	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	19.36	12.75	4.71	5.82	7.82	8.65
Secured Loans	1.07	1.89	2.63	2.77	2.98	5.13
Unsecured Loans	0.00	7.31	8.78	8.29	8.25	7.27
Total Debt	1.07	9.20	11.41	11.06	11.23	12.40
Total Liabilities	20.43	21.95	16.12	16.88	19.05	21.05
APPLICATION OF FUNDS :
Gross Block	0.93	0.87	0.87	0.87	0.87	0.87
Less : Accumulated Depreciation	0.50	0.43	0.39	0.34	0.30	0.25
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	0.43	0.44	0.48	0.53	0.57	0.62
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	10.03	10.07	10.07	10.07	10.07	10.02
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.58	0.79	0.58	0.15	0.42	0.41
Sundry Debtors	1.08	1.86	0.43	2.06	2.50	4.04
Cash and Bank	1.28	4.35	0.11	0.12	-0.52	0.03
Loans and Advances	3.56	1.16	4.56	4.60	4.72	5.07
Total Current Assets	6.49	8.16	5.68	6.94	7.12	9.55
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	0.93	1.57	1.50	1.75	1.34	2.09
Provisions	0.00	0.01	0.00	0.00	0.00	0.00
Total Current Liabilities	0.93	1.58	1.50	1.75	1.34	2.09
Net Current Assets	5.57	6.58	4.18	5.18	5.78	7.46
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	1.31	1.70	1.90	1.63	3.10	3.69
Deferred Tax Liability	0.64	0.63	0.59	0.57	0.51	0.78
Net Deferred Tax	0.67	1.07	1.31	1.06	2.59	2.91
Total Assets	16.70	18.16	16.05	16.84	19.01	21.01
Contingent Liabilities	2.28	2.28	0.63	0.63	0.63	0.63

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	11.49	9.81	8.50	8.50	8.50	8.50
Reserves Total	50.67	36.55	24.04	24.29	27.23	24.01
Equity Share Warrants	0.00	1.82	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	62.16	48.18	32.54	32.79	35.73	32.51
Minority Interest	0.11	0.09	0.08	0.07	0.08	0.07
Secured Loans	22.72	27.48	21.54	29.65	29.61	29.69
Unsecured Loans	32.00	41.60	37.36	21.58	12.33	6.94
Total Debt	54.72	69.08	58.90	51.23	41.94	36.63
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	0.51	0.47	0.26	0.27	0.29	0.23
Total Liabilities	117.50	117.82	91.78	84.36	78.04	69.44
APPLICATION OF FUNDS :
Gross Block	108.00	97.25	79.40	72.73	61.65	50.47
Less: Accumulated Depreciation	31.20	25.30	19.73	15.05	10.59	6.77
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	76.80	71.95	59.67	57.68	51.06	43.70
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	2.33	3.34	4.91	2.91	0.14	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.16	0.22	0.22	0.22	0.21	0.23
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	21.69	19.93	10.79	11.15	8.47	7.67
Sundry Debtors	27.89	38.08	16.71	23.08	19.18	18.66
Cash and Bank	2.78	5.78	1.27	1.30	0.60	1.61
Loans and Advances	4.96	7.24	10.47	10.08	8.65	8.52
Total Current Assets	57.32	71.03	39.24	45.61	36.90	36.46
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	23.08	31.83	12.55	21.07	15.90	17.24
Provisions	0.58	0.64	0.06	0.03	0.04	0.02
Total Current Liabilities	23.65	32.47	12.61	21.10	15.94	17.26
Net Current Assets	33.67	38.56	26.63	24.51	20.96	19.20
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	2.38	3.19	3.77
Deferred Tax Liability	3.93	3.17	1.87	4.07	3.90	4.44
Net Deferred Tax	-3.93	-3.17	-1.87	-1.69	-0.71	-0.67
Other Assets	8.45	6.92	2.22	0.73	6.37	6.98
Total Assets
Contingent Liabilities	2.74	2.74	0.73	0.97	0.97	2.40

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	4.33	0.10	0.11	-0.53	0.02
Net Cash from Operating Activities	-0.28	-0.36	0.47	2.20	1.68
Net Cash Used In Investing Activities	0.14	0.00	0.00	-0.01	0.03
Net Cash Used In Financing Activities	-2.92	4.59	-0.48	-1.55	-2.25
Net Inc./Dec In Cash And Cash Equivalents	-3.07	4.23	-0.01	0.64	-0.55
Cash And Cash Equivalents At End Of The Year	1.27	4.33	0.10	0.11	-0.53

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

72.30%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

27.70%

**Promoter pledged shareholding 72.30%

About Parnax Lab Ltd

Parnax Lab Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 128.52 crores. It has reported a sales of Rs. 2.77 crores and a net profit of Rs. 0.99 crores for the quarter ended December 2018. The company management includes , Vindyak B Desai,Prakash M Shah,Baiju M Shah,Ami M Shah,T V Anantharaman,Yogesh Varia,Harish S Panpalia (Parnax Lab Ltd) among others.

Chairman

Registered office

Gala 114 Bldg No 8,Jogani Ind Complex Chunabhatti,Mumbai,Maharashtra,400022

FAX :91-022-2405 7728

Background

Incorporation Year1982

Face Value₹10

Market Lot50

How to buy shares on nse?

To buy shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the share price today?

The shares price on nse is Rs.0 today.

What is the market cap of shares on ?

The company has a market capitalization of Rs.0.00Cr

What is the PE & PB ratio of shares ?

PE is 0 and PB is 0

What is the 52 Week High and Low of shares?

stock price high: Rs.0 stock price low: Rs.0